HOME >> BIOLOGY >> NEWS
New study shows hope for treating inhalant abuse

UPTON, N.Y. -- A new study by scientists at the U.S. Department of Energy's Brookhaven National Laboratory suggests that vigabatrin (a.k.a. gamma vinyl-GABA or GVG) may block the addictive effects of toluene, a substance found in many household products commonly used as inhalants. These results broaden the promise of GVG as a potential treatment for a variety of addictions. The study will be published in the December 1, 2004 issue of Synapse, available online September 30.

Inhalant abuse or "huffing" continues to grow as a serious health problem: According to the National Institute on Drug Abuse, the number of new inhalant users increased from 627,000 in 1994 to 1.2 million in 2000. The chronic use of inhalants has been associated with heart, liver, kidney, and brain damage -- and can even result in sudden death.

The Brookhaven Lab study demonstrates that animals previously trained to expect toluene in a given location spent far less time "seeking" toluene in that location after being treated with GVG than animals treated with a placebo. This elimination of conditioned place preference -- a model of craving in which animals develop a preference for a place where they have previously had access to a drug, even when the drug is absent -- is similar to the aversion seen in Brookhaven's earlier studies of GVG with nicotine and heroin.

"The findings of this study extend the potential value of GVG to treat addiction," says Stephen Dewey, the Brookhaven Lab neuroanatomist who led the study. "More importantly, our results show promise in treating inhalant abuse as it continues to grow as a problem among adolescents." There are currently no pharmaceutical treatments for inhalant abuse.

The study was conducted by putting rats through a series of conditioning tests. The tests were intended to condition the animals to learn which chambers of a three-chambered apparatus contained toluene vapors. On the final day of the study, scientist
'"/>

Contact: Dennis Tartaglia
dennist@mbooth.com
212-481-7000
M Booth & Associates
30-Sep-2004


Page: 1 2 3

Related biology news :

1. Student science contest participation influences study, career choices, alumni say
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
4. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
5. Phase II trials of second-generation antisense cancer drug planned following successful early study
6. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
7. Indiana University, EPA to study airborne PCBs
8. K-State, other universities to study how climate affects plant evolution
9. USC study links historical increases in life span to lower childhood exposure to infection
10. Washington University in St. Louis leads group studying aging process
11. Simian virus 40 not associated with non-Hodgkin lymphoma, study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2020)... (PRWEB) , ... March 20, 2020 , ... ... development of human embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC), through ... for the treatment of neurological, autoimmune, and rare orphan diseases, today announced that ...
(Date:3/13/2020)... ... March 13, 2020 , ... Acumed LLC today announced that ... distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, ... calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will continue ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and to expand ... Diego, California. Phoenestra is a biotech company located in Austria. , Phoenestra ...
Breaking Biology News(10 mins):
(Date:3/4/2020)... ... March 04, 2020 , ... ... services, today announced the launch of its FleXpress™ high-throughput recombinant antibody production ... of antibodies at 80 ml scale. All production occurs in Absolute Antibody’s ...
(Date:2/28/2020)... SAN DIEGO (PRWEB) , ... February 26, 2020 ... ... HS7 system combines a high-speed camera with a dedicated controller, thus ... 2500 frames per second, the HS7 is the first of Fastec Imaging’s new ...
(Date:2/21/2020)... ... February 21, 2020 , ... Join Forrest Brown, Engineering Services Manager – Northeast ... for an informative session on Wednesday, February 26, 2020 at 1pm ... incorporate into facility design to add manufacturing flexibility in the future, especially for CMOs ...
(Date:2/13/2020)... ... , ... Arriello , a provider of market access, ... Safety™ as part of the company’s continued growth in pharmacovigilance operations. , ... information such as SUSARs and ICSRS, aggregate report production, signal management, and management ...
Breaking Biology Technology:
Cached News: